May 20th, 2014
Hopes and Beliefs: How Patients Respond to Informed-Consent Tools
Todd K. Rosengart, MD
In an article recently published in Annals of Thoracic Surgery, investigators describe results of a randomized comparison of two different instruments for providing informed consent to 240 patients scheduled for elective cardiac catheterization with possible PCI: a scripted verbal or written presentation and a commercially available, web-based, audiovisual presentation (provided for free by the developer). They found that although both instruments significantly increased patient understanding in two of three key domains (risks and alternatives), the audiovisual instrument outperformed the verbal or written instrument only in the identification of alternative treatments, and neither instrument significantly increased patient understanding of the benefits of the procedure.
CardioExchange Editor-in-Chief Harlan Krumholz discusses the findings with the paper’s senior author, Todd Rosengart, MD.
Harlan Krumholz: The paper is quite interesting. What surprised you most about your findings?
Todd Rosengart: We were amazed that so many patients still heard and believed what they were most hopeful for, such as that PCI would “cure their disease,” especially when corrective counter-information was provided. We were surprised, despite some improvements provided by the audiovisual consent process, that the outcomes were not even better. It taught us that the information provided in the consent tool needs to be carefully thought through to deliver the intended message.
Krumholz: Why didn’t you enroll more patients?
Rosengart: Timing issues led to our termination of the study earlier than expected. Given that there were no discernable trends toward an improvement in comprehension with the audiovisual device in most categories beyond those already identified, in part because of the issues noted above, we concluded that outcomes would have remained largely unchanged even with larger enrollment numbers.
Krumholz: Why did you publish this paper in a surgical journal, since the topic was PCI and cath?
Rosengart: Surgeons as well as cardiologist and PCPs have harbored great concerns regarding the success of current PCI consenting processes in adequately informing patients about the risks and benefits of PCI, as well as alternatives to PCI such as surgery. This study was designed to inform the surgical as well as the medical community as to the adequacy of current processes and the availability of potential improvements, such as the tested audiovisual consenting tool.
Krumholz: What do you believe are the main reasons that patients have misperceptions? We published a paper on this a decade ago; in 2010, Rothberg and colleagues repeated it and found the same results. Both were single-center studies, but the results were the same — decades apart. Why is this so?
Rosengart: As you know, this has been the subject of much investigation — including psychological analyses. It is interesting that aspirational goals (“this will make me better”) are less well-conceptualized (overestimated) than potential risks, which were relatively well understood. As noted in the paper, this seems to correlate well with physicians’ own well-documented inflated perceptions of procedural benefits as well as with the psychology of wanting to feel and be “better.” All of the above underline the need for diligent, objective transfer of information.
Krumholz: Why didn’t this intervention work? What did it make you think of the product that is being sold?
Rosengart: As noted above, our data highlighted the need for further improvements and expansion of information conveyed in such products, which we believe can be effective if so enhanced.
Krumholz: What are the next steps?
Rosengart: Further improvements in the informational content of the audiovisual tool have been recommended. We look forward to further testing of such tools.
Categories: General
Tags: informed consent, Interventional Cardiology, patient expectations, patient-physician interaction, PCI
You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.
3 Responses to “Hopes and Beliefs: How Patients Respond to Informed-Consent Tools”
Pages
Archives
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
Categories
- Anticoagulation (172)
- Cardiac Imaging (70)
- Cardiac Surgery (173)
- Electrophysiology (248)
- Events (29)
- General (1,653)
- Heart Failure (191)
- Hypertension (12)
- Interventional Cardiology (3)
- Pediatric Cardiology (3)
- Prevention (705)
- Vascular (68)
-
Tag Cloud
- ACS AF AHA anticoagulation aortic valve replacement apixaban aspirin atrial fibrillation CABG cardiovascular risk cholesterol clopidogrel dabigatran diabetes diet drug-eluting stents epidemiology ESC exercise FDA FDA approvals Fellowship training guidelines HDL heart failure hypertension ICDs MI myocardial infarction obesity PCI Primary PCI risk factors rivaroxaban statins STEMI stents stroke stroke prevention TAVI TAVR type 2 diabetes venous thromboembolism warfarin women

Congratulations on an important study. Having not seen the video, I will assume that it went through rigorous development, with feedback from clinicians and patients, and that it is quite decent. So I am not really convinced that the next step should be educational tool improvement. What do you think would be different the next time around, and should better knowledge scores be the goal? Have we advanced the patient’s health, experience, outcomes?
“Doctor House vs Robocop”
Thank you for this nice study and well conducted discussion.
This makes me think that we are only human beings, sharing emotion with our patients.
This is well summarized in the remark of Dr Rosengart “physicians’ perception of procedural benefits” it explains why most of the patients (fortunately) keep in mind the positive of the procedure when explain them on an emphatic way (because we believe it is the good one!) .
A robot without any emotional participation (uniform sight, monochord speech, unchanging gestures…) will probably collect different informed consents.
This can be the subject of a following study.” Informed consent signed in front of Robocop”
In my experience most of the people use a thinking process very different from the one we use after years of study and experience. A great deal of people base their decision on their own experience, advice from family and friends and of course from Internet, not necessarily from scientific evidence, and who can blame them this days you can find scientific evidence in any directions in a lot of subject. Most of the people is susceptible to advertising that’s why is a well known profession. Many people go to the doctor complaining of pain, so nobody likes pain and discomfort so everybody prefer comfortable procedures. At the end for a lot of people their medical decision are and act of faith, they prepare for the worst and hope for the best.